SCHEMBL4513876

SCHEMBL4513876

COc1ccc(S(=O)(=O)N(C)c2ccc(Cl)cc2)c2c1C[C@@H](N(C)C(=O)C(F)(F)F)CC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.51
QRFPR Q96P65 1/20 0.51
MAPT P10636 2/20 0.35
NR2F2 P24468 1/20 0.35
RAB9A P51151 1/20 0.35
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
ERAP1 Q9NZ08 2/20 0.34
LTC4S Q16873 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
ACHE P22303 1/20 0.32
CYP1A2 P05177 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4966066 1.00 HTR6 (0.51) HTR6QRFPRMAPTNR2F2RAB9A
SCHEMBL4518652 0.85 HTR6 (0.50) HTR6QRFPRCA1CA2ACHE
SCHEMBL4514566 0.78 HTR6 (0.49) HTR6QRFPRMAPTNR2F2RAB9A
SCHEMBL4519658 0.77 HTR6 (0.52) HTR6QRFPRERAP1MEN1KMT2A
SCHEMBL4530432 0.75 HTR6 (0.51) HTR6QRFPRMAPTLMNAMEN1
SCHEMBL4519708 0.72 CHRM2 (0.64) MAPTCA1CA2ACHECYP1A2
SCHEMBL4515625 0.71 HTR6 (0.38) HTR6QRFPRLMNAGAA
SCHEMBL4518671 0.71 HTR6 (0.78) HTR6QRFPRMAPTLMNAMEN1
SCHEMBL4209430 0.70 HTR6 (0.42) HTR6QRFPRCHRM2CHRM1CHRM3
SCHEMBL13942853 0.70 HTR6 (0.41) HTR6QRFPRNR1H2NR1H3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor ASTRAZENECA AB (SE) 2009-04-16 US disclosed
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor ASTRAZENECA AB (SE) 2009-04-16 US disclosed
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor ASTRAZENECA AB (SE) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor HTR6, HTR1D, HTR1A HTR6 1/4885QRFPR 79/4885MAPT 2173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.